Literature DB >> 21527915

Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells.

Michal Amit1, Ilana Laevsky, Yael Miropolsky, Kohava Shariki, Meital Peri, Joseph Itskovitz-Eldor.   

Abstract

Human pluripotent (embryonic or induced) stem cells (hPSCs) have many potential applications, not only for research purposes but also for clinical and industrial uses. While culturing these cells as undifferentiated lines, an adherent cell culture based on supportive layers or matrices is most often used. However, the use of hPSCs for industrial or clinical applications requires a scalable, reproducible and controlled process. Here we present a suspension culture system for undifferentiated hPSCs, based on a serum-free medium supplemented with interleukins and basic fibroblast growth factor, suitable for the mass production of these cells. The described system supports a suspension culture of hPSC lines, in both static and dynamic cultures. Results showed that hPSCs cultured with the described dynamic method maintained all hPSC features after 20 passages, including stable karyotype and pluripotency, and increased in cell numbers by 25-fold in 10 d. Thus, the described suspension method is suitable for large-scale culture of undifferentiated hPSCs.

Entities:  

Mesh:

Year:  2011        PMID: 21527915     DOI: 10.1038/nprot.2011.325

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  32 in total

1.  Scalable pluripotent stem cell culture.

Authors:  Larry A Couture
Journal:  Nat Biotechnol       Date:  2010-06       Impact factor: 54.908

2.  Long-term microcarrier suspension cultures of human embryonic stem cells.

Authors:  Steve K W Oh; Allen K Chen; Yanglin Mok; Xiaoli Chen; U-Ming Lim; Angela Chin; Andre B H Choo; Shaul Reuveny
Journal:  Stem Cell Res       Date:  2009-03-04       Impact factor: 2.020

3.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides.

Authors:  A G Smith; J K Heath; D D Donaldson; G G Wong; J Moreau; M Stahl; D Rogers
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

Review 4.  Derivation and spontaneous differentiation of human embryonic stem cells.

Authors:  Michal Amit; Joseph Itskovitz-Eldor
Journal:  J Anat       Date:  2002-03       Impact factor: 2.610

5.  Human feeder layers for human embryonic stem cells.

Authors:  M Amit; V Margulets; H Segev; K Shariki; I Laevsky; R Coleman; J Itskovitz-Eldor
Journal:  Biol Reprod       Date:  2003-01-22       Impact factor: 4.285

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.

Authors:  Noboru Sato; Laurent Meijer; Leandros Skaltsounis; Paul Greengard; Ali H Brivanlou
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

9.  Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells.

Authors:  J C Conover; N Y Ip; W T Poueymirou; B Bates; M P Goldfarb; T M DeChiara; G D Yancopoulos
Journal:  Development       Date:  1993-11       Impact factor: 6.868

10.  Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells.

Authors:  Igal Germanguz; Oshra Sedan; Naama Zeevi-Levin; Ronit Shtrichman; Efrat Barak; Anna Ziskind; Sivan Eliyahu; Gideon Meiry; Michal Amit; Joseph Itskovitz-Eldor; Ofer Binah
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

View more
  49 in total

Review 1.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

2.  Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.

Authors:  Henning Kempf; Christina Kropp; Ruth Olmer; Ulrich Martin; Robert Zweigerdt
Journal:  Nat Protoc       Date:  2015-08-13       Impact factor: 13.491

3.  Pluripotent and somatic stem cells: from basic science to utilization in disease modeling and therapeutic application. Meeting report on the 7th International Meeting of the Stem Cell Network North Rhine Westphalia.

Authors:  Stefan Radtke; Peter A Horn
Journal:  Cell Reprogram       Date:  2013-09-10       Impact factor: 1.987

4.  Cultured Cells from the Human Oocyte Cumulus Niche Are Efficient Feeders to Propagate Pluripotent Stem Cells.

Authors:  Said Assou; Emilie Pourret; Marie Péquignot; Valérie Rigau; Vasiliki Kalatzis; Ounissa Aït-Ahmed; Samir Hamamah
Journal:  Stem Cells Dev       Date:  2015-07-08       Impact factor: 3.272

Review 5.  Developing defined culture systems for human pluripotent stem cells.

Authors:  Bahram Valamehr; Hideaki Tsutsui; Chih-Ming Ho; Hong Wu
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

6.  Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System.

Authors:  Michael K Conway; Michael J Gerger; Erin E Balay; Rachel O'Connell; Seth Hanson; Neil J Daily; Tetsuro Wakatsuki
Journal:  J Vis Exp       Date:  2015-05-14       Impact factor: 1.355

7.  Adapting human pluripotent stem cells to high-throughput and high-content screening.

Authors:  Sabrina C Desbordes; Lorenz Studer
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

8.  Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability.

Authors:  Michaela Kunova; Kamil Matulka; Livia Eiselleova; Anton Salykin; Iva Kubikova; Sergiy Kyrylenko; Ales Hampl; Petr Dvorak
Journal:  Stem Cells Transl Med       Date:  2013-03-13       Impact factor: 6.940

Review 9.  Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.

Authors:  Inbar Budniatzky; Lior Gepstein
Journal:  Stem Cells Transl Med       Date:  2014-03-03       Impact factor: 6.940

10.  Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells.

Authors:  Sarah A Konze; Laura van Diepen; Anke Schröder; Ruth Olmer; Hanna Möller; Andreas Pich; Robert Weißmann; Andreas W Kuss; Robert Zweigerdt; Falk F R Buettner
Journal:  Mol Cell Proteomics       Date:  2014-01-30       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.